NMR-based metabolomics and machine learning show promise for non-invasive disease screening in dogs
By
Riccardo Finotello, Shao Thing Teoh, Hamed Nili, Mohammad Sepehri, Ylenia Cuzzupè, Simone Scoccianti, Fabio Procoli, Daniel C. Anthony, Livia Benigni, Mara Vittoria Alonzo, Islom B. Nazarov
Summary
This study evaluates the use of NMR-based metabolomics combined with machine learning for non-invasive disease screening in dogs, specifically for cancer, cardiovascular disease (CVD), and overall health status. Blood samples were collected from 139 client-owned dogs after exclusions, and classification models were trained and cross-validated. The research highlights the potential of metabolomics as a diagnostic tool in veterinary medicine, drawing on established applications in human medicine.
Source
Key quotes
· 3 pulledBlood-based metabolomics is increasingly recognised as a powerful tool for disease detection in human medicine.
However, its application in veterinary science remains limited.
To evaluate the ability of an NMR-based metabolomics platform combined with machine learning to screen dogs for cancer, cardiovascular disease (CVD), and overall health status.
You might also wanna read
New MRI-Based Biomarker Predicts Aging and Disease Risks
Researchers from Duke University, Harvard University, and the University of Otago have developed DunedinPACNI, a noninvasive MRI-based bioma
insideprecisionmedicine.com·11mo agoMySuppleHub: Community Supplement Encyclopedia

Microbial metabolite restores liver health by targeting PPARα and lipid metabolism through the gut-liver axis
This scientific research article reports on the therapeutic potential of a microbial metabolite (10-hydroxy-10-hydr) in alleviating liver in
Biomarkers and Longevity: What Health Tests Can and Can't Tell You
This article explores the growing trend of using biomarkers—measurable biological signs—as tools for health optimization and longevity. It e

NIH-funded study finds circular RNA blood test outperforms leading diagnostic for predicting Alzheimer's progression
A new NIH-funded study has identified circular RNAs (circRNAs) in the blood as a novel biomarker for Alzheimer's disease. Elevated levels of

AI-based OCT analysis reveals plaque composition changes after intensive lipid-lowering therapy in non-obstructive coronary lesions: YELLOW III sub-study
This YELLOW III sub-study investigates the impact of intensive lipid-lowering therapy on non-obstructive coronary plaques using AI-based tis

Comments
Sign in to join the conversation.
No comments yet. Be the first.